國立虎尾科技大學 |

Breast Cancer Biology for the Radiation Oncologist

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Breast Cancer Biology for the Radiation Oncologist/ edited by Jonathan Strauss, William Small, Gayle E. Woloschak.
other author:	Strauss, Jonathan.
Description:	VII, 90 p. 15 illus., 5 illus. in color.online resource. :
Contained By:	Springer Nature eBook
Subject:	Radiotherapy. -
Online resource:	https://doi.org/10.1007/978-3-642-31220-5
ISBN:	9783642312205

Breast Cancer Biology for the Radiation Oncologist
Breast Cancer Biology for the Radiation Oncologist[electronic resource] /edited by Jonathan Strauss, William Small, Gayle E. Woloschak. - 1st ed. 2015. - VII, 90 p. 15 illus., 5 illus. in color.online resource. - Radiation Oncology. - Radiation Oncology.

Biological subtypes of breast cancer -- Oncogene amplification and Herceptin -- Current clinical use of genetic profiling -- Biology of DCIS and progression to invasive disease -- Cancer Stem Cells and Radiotherapy -- Genetic basis of normal tissue radiosensitivity and late toxicity -- Genetic syndromes and radiotherapy in breast cancer -- Experimental therapies in breast cancer.

Breast Cancer Biology for the Radiation Oncologist is the first textbook of its kind devoted to describing the biological complexities of breast cancer in a way that is relevant to the radiation oncologist. Radiation Oncology has long treated breast cancer as a single biological entity, with all treatment decisions being based on clinical and pathologic risk factors. We are now beginning to understand that biological subtypes of breast cancer may have different risks of recurrence as well as different intrinsic sensitivity to radiotherapy. Multi-gene arrays that have for years been used to predict the risk of distant recurrence and the value of systemic chemotherapy may also have utility in predicting the risk of local recurrence. Additionally, the targeted agents used to treat breast cancer may interact with radiotherapy in ways that can be beneficial or undesirable. All of these emerging issues of central importance to radiation oncologists are extensively discussed in this book, and practical treatment recommendations based on available clinical evidence are presented whenever possible.

ISBN: 9783642312205

Standard No.: 10.1007/978-3-642-31220-5doiSubjects--Topical Terms:

593952
Radiotherapy.

LC Class. No.: RM845-862.5

Dewey Class. No.: 615.842

Breast Cancer Biology for the Radiation Oncologist
LDR:02901nam a22004095i 4500 001 969261
003 DE-He213
005 20200705212552.0
007 cr nn 008mamaa
008 201211s2015 gw | s |||| 0|eng d
020 $a 9783642312205 $9 978-3-642-31220-5
024 7 $a 10.1007/978-3-642-31220-5 $2 doi
035 $a 978-3-642-31220-5
050 4 $a RM845-862.5
072 7 $a MJCL1 $2 bicssc
072 7 $a MED080000 $2 bisacsh
072 7 $a MJCL1 $2 thema
082 0 4 $a 615.842 $2 23
245 1 0 $a Breast Cancer Biology for the Radiation Oncologist $h [electronic resource] / $c edited by Jonathan Strauss, William Small, Gayle E. Woloschak.
250 $a 1st ed. 2015.
264 1 $a Berlin, Heidelberg : $b Springer Berlin Heidelberg : $b Imprint: Springer, $c 2015.
300 $a VII, 90 p. 15 illus., 5 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
490 1 $a Radiation Oncology
505 0 $a Biological subtypes of breast cancer -- Oncogene amplification and Herceptin -- Current clinical use of genetic profiling -- Biology of DCIS and progression to invasive disease -- Cancer Stem Cells and Radiotherapy -- Genetic basis of normal tissue radiosensitivity and late toxicity -- Genetic syndromes and radiotherapy in breast cancer -- Experimental therapies in breast cancer.
520 $a Breast Cancer Biology for the Radiation Oncologist is the first textbook of its kind devoted to describing the biological complexities of breast cancer in a way that is relevant to the radiation oncologist. Radiation Oncology has long treated breast cancer as a single biological entity, with all treatment decisions being based on clinical and pathologic risk factors. We are now beginning to understand that biological subtypes of breast cancer may have different risks of recurrence as well as different intrinsic sensitivity to radiotherapy. Multi-gene arrays that have for years been used to predict the risk of distant recurrence and the value of systemic chemotherapy may also have utility in predicting the risk of local recurrence. Additionally, the targeted agents used to treat breast cancer may interact with radiotherapy in ways that can be beneficial or undesirable. All of these emerging issues of central importance to radiation oncologists are extensively discussed in this book, and practical treatment recommendations based on available clinical evidence are presented whenever possible.
650 0 $a Radiotherapy. $3 593952
650 0 $a Oncology . $3 1253469
650 2 4 $a Oncology. $3 593951
700 1 $a Strauss, Jonathan. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1264840
700 1 $a Small, William. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1264841
700 1 $a Woloschak, Gayle E. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1264842
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783642312212
776 0 8 $i Printed edition: $z 9783642312199
776 0 8 $i Printed edition: $z 9783662520741
830 0 $a Radiation Oncology $3 1254698
856 4 0 $u https://doi.org/10.1007/978-3-642-31220-5
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)